Biomedical Textiles Market by Fiber Type (Biodegradable, Non-biodegradable), Fabric Type (Woven, Non-woven), Application (Non-implantable, Surgical Sutures), and Region (North America, Europe, Asia Pacific, MEA, South America) - Global Forecast to 2022
“The biomedical textiles market is projected to grow at a CAGR of 5.7% from 2017 to 2022, in terms of value.”
The biomedical textiles market is estimated to be USD 10.99 billion in 2017 and is projected to reach USD 14.50 billion by 2022, at a CAGR of 5.7% between 2017 and 2022. The increasing demand for biomedical textiles in bandages, surgical sutures, implants, and extracorporeal devices is one of the most significant factors driving the growth of the biomedical textiles market. The rise in the number of aging population and the increasing number of surgeries have also contributed to the growth of the biomedical textiles market. However, the need for high R&D investments is restraining the growth of the biomedical textiles market.
“The non-woven fabric segment is projected to lead the biomedical textiles market during the forecast period.”
Based on fabric type, the non-woven fabric segment accounted for the major share of the biomedical textiles market in 2016 and is also projected to grow at the highest CAGR during the forecast period owing to the high demand from non-implantable applications, such as gauze, cohesive, adhesive, tubular, and triangular bandages. Non-woven fabrics are unique, high-tech, and engineered fabrics used across a wide range of applications and products. Increasing awareness and the benefits of using this fabric type in the healthcare industry is expected to propel its demand between 2017 and 2022.
“The non-implantable application segment is projected to grow at the highest CAGR during the forecast period.”
Based on application, the non-implantable segment of the biomedical textiles market is expected to register the highest CAGR between 2017 and 2022. The demand for biomedical textiles in the non-implantable application is mainly driven by an increase in consumption of wound care products, such as gauzes, adhesive bandages, cohesive bandages, and others. The increasing number of accidents and surgeries is driving the market for biomedical textiles in non-implantable applications.
“The non-biodegradable fiber segment is projected to grow at the highest CAGR during the forecast period.”
Based on fiber type, the non-biodegradable segment is estimated to dominate the biomedical textiles market in 2017. The dominance can be attributed to the growing demand for non-biodegradable fibers, such as polypropylene, polyethylene, polyamide, and polyester, in non-implantable applications. These fibers are also widely used in many surgical sutures, implants, and extracorporeal devices.
“The biomedical textiles market in the Asia Pacific region is projected to grow at the highest CAGR between 2017 and 2022.”
The Asia Pacific (APAC) biomedical textiles market is projected to grow at the highest CAGR during the forecast period. Companies manufacturing biomedical textiles have ample growth opportunities in this market owing to the availability of cheap labor and raw materials. The consumption of biomedical textiles is also high in this region due to densely populated countries, such as India and China. Additionally, the increasing government expenditure on healthcare facilities and rising income are also propelling the growth of the biomedical textiles market in APAC. Furthermore, the initiative taken by the Indian government to indigenously manufacture products under the “Make in India” initiative, is also expected to contribute to the growth of the APAC biomedical textiles market. For instance, the state government of Gujarat (India) is setting two new Technical Textile (TT) zones to be developed in Ahmedabad and Surat districts. The growth in technical textiles will directly influence the growth of the biomedical textiles market in the APAC region.
In the process of determining and verifying the market size for several segments and subsegments gathered through secondary research, extensive primary interviews have been conducted as follows:
This report covers the biomedical textiles market and forecasts the size of the market till 2022. The report includes the segmentation of the biomedical textiles market based on fabric type, fiber type, application, and region. Porter’s five forces analysis and key market dynamics, such as drivers, restraints, challenges, and opportunities influencing the growth of the biomedical textiles market have been discussed in the report. The report also provides company profiles and competitive benchmarking of major players operating in the biomedical textiles market.
Benefits of Buying the Report:
The report is expected to help market leaders/new entrants in the biomedical textiles market in the following ways:
The biomedical textiles market is estimated to be USD 10.99 billion in 2017 and is projected to reach USD 14.50 billion by 2022, at a CAGR of 5.7% between 2017 and 2022. The increasing demand for biomedical textiles in bandages, surgical sutures, implants, and extracorporeal devices is one of the most significant factors driving the growth of the biomedical textiles market. The rise in the number of aging population and the increasing number of surgeries have also contributed to the growth of the biomedical textiles market. However, the need for high R&D investments is restraining the growth of the biomedical textiles market.
“The non-woven fabric segment is projected to lead the biomedical textiles market during the forecast period.”
Based on fabric type, the non-woven fabric segment accounted for the major share of the biomedical textiles market in 2016 and is also projected to grow at the highest CAGR during the forecast period owing to the high demand from non-implantable applications, such as gauze, cohesive, adhesive, tubular, and triangular bandages. Non-woven fabrics are unique, high-tech, and engineered fabrics used across a wide range of applications and products. Increasing awareness and the benefits of using this fabric type in the healthcare industry is expected to propel its demand between 2017 and 2022.
“The non-implantable application segment is projected to grow at the highest CAGR during the forecast period.”
Based on application, the non-implantable segment of the biomedical textiles market is expected to register the highest CAGR between 2017 and 2022. The demand for biomedical textiles in the non-implantable application is mainly driven by an increase in consumption of wound care products, such as gauzes, adhesive bandages, cohesive bandages, and others. The increasing number of accidents and surgeries is driving the market for biomedical textiles in non-implantable applications.
“The non-biodegradable fiber segment is projected to grow at the highest CAGR during the forecast period.”
Based on fiber type, the non-biodegradable segment is estimated to dominate the biomedical textiles market in 2017. The dominance can be attributed to the growing demand for non-biodegradable fibers, such as polypropylene, polyethylene, polyamide, and polyester, in non-implantable applications. These fibers are also widely used in many surgical sutures, implants, and extracorporeal devices.
“The biomedical textiles market in the Asia Pacific region is projected to grow at the highest CAGR between 2017 and 2022.”
The Asia Pacific (APAC) biomedical textiles market is projected to grow at the highest CAGR during the forecast period. Companies manufacturing biomedical textiles have ample growth opportunities in this market owing to the availability of cheap labor and raw materials. The consumption of biomedical textiles is also high in this region due to densely populated countries, such as India and China. Additionally, the increasing government expenditure on healthcare facilities and rising income are also propelling the growth of the biomedical textiles market in APAC. Furthermore, the initiative taken by the Indian government to indigenously manufacture products under the “Make in India” initiative, is also expected to contribute to the growth of the APAC biomedical textiles market. For instance, the state government of Gujarat (India) is setting two new Technical Textile (TT) zones to be developed in Ahmedabad and Surat districts. The growth in technical textiles will directly influence the growth of the biomedical textiles market in the APAC region.
In the process of determining and verifying the market size for several segments and subsegments gathered through secondary research, extensive primary interviews have been conducted as follows:
- By Company Type- Tier 1 - 10%, Tier 2 - 25%, and Tier 3 - 65%
- By Designation- C level - 10%, Director level - 30%, and Others - 60%
- By Region- Asia Pacific - 45%, North America - 20%, Europe - 15%, South America - 11%, and Middle East & Africa - 9%
- Royal DSM (Netherlands)
- Covidien (Ireland)
- Integra Life Sciences (US)
- Johnson & Johnson (US)
- Smith & Nephew (UK)
- Medline Industries (US)
- B. Braun Melsungen (Germany)
- Cardinal Health (US)
- Paul Hartmann (Germany)
- BSN Medical (Germany)
This report covers the biomedical textiles market and forecasts the size of the market till 2022. The report includes the segmentation of the biomedical textiles market based on fabric type, fiber type, application, and region. Porter’s five forces analysis and key market dynamics, such as drivers, restraints, challenges, and opportunities influencing the growth of the biomedical textiles market have been discussed in the report. The report also provides company profiles and competitive benchmarking of major players operating in the biomedical textiles market.
Benefits of Buying the Report:
The report is expected to help market leaders/new entrants in the biomedical textiles market in the following ways:
- This report segments the biomedical textiles market and provides the closest approximation of revenues for the overall market and its subsegments across different verticals and regions.
- The report helps stakeholders understand the pulse of the market and provides information on key drivers, restraints, challenges, and opportunities of the biomedical textiles market.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.2 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 SIGNIFICANT OPPORTUNITIES IN THE BIOMEDICAL TEXTILES MARKET
4.2 BIOMEDICAL TEXTILES MARKET, BY APPLICATION
4.3 BIOMEDICAL TEXTILES MARKET, BY COUNTRY AND REGION
4.4 US BIOMEDICAL TEXTILES MARKET, BY APPLICATION
4.5 BIOMEDICAL TEXTILES MARKET ATTRACTIVENESS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising number of surgeries
5.2.1.2 Rapid growth in aging population
5.2.1.3 High quality of biomedical textiles
5.2.1.4 Growing need for advanced wound dressing material
5.2.2 RESTRAINTS
5.2.2.1 High R&D investments
5.2.3 OPPORTUNITIES
5.2.3.1 Development of smart biomedical textiles
5.2.3.2 Growing demand from emerging markets
5.2.4 CHALLENGES
5.2.4.1 Increasing pricing pressure on market players
5.2.4.2 Product marketing
5.3 PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 INDUSTRY OUTLOOK
5.4.1 CONTRIBUTION OF THE HEALTHCARE INDUSTRY TO GDP
6 BIOMEDICAL TEXTILES MARKET, BY FIBER TYPE
6.1 INTRODUCTION
6.2 NON-BIODEGRADABLE FIBER
6.2.1 POLYPROPYLENE AND POLYETHYLENE
6.2.2 COTTON
6.2.3 VISCOSE
6.2.4 POLYESTER
6.2.5 POLYAMIDE
6.2.6 OTHERS
6.2.6.1 Polyurethane
6.2.6.2 Polytetrafluoroethylene(PTFE)
6.3 BIODEGRADABLE FIBER
6.3.1 COLLAGEN
6.3.2 CHITIN
6.3.3 OTHERS
7 BIOMEDICAL TEXTILES MARKET, BY FABRIC TYPE
7.1 INTRODUCTION
7.2 NON-WOVEN FABRIC
7.3 WOVEN FABRIC
7.4 OTHERS
7.4.1 KNITTED & BRAIDED FABRICS
7.4.2 HOLLOW FABRIC
8 BIOMEDICAL TEXTILES MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 NON-IMPLANTable
8.2.1 BANDAGES
8.3 SURGICAL SUTURES
8.4 OTHERS
8.4.1 IMPLANTable
8.4.1.1 Soft tissue implants
8.4.1.2 Hard tissue implants
8.4.1.3 Dental prosthesis
8.4.1.4 Vascular devices
8.4.2 EXTRACORPOREAL DEVICES
9 BIOMEDICAL TEXTILES MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.2.3 MEXICO
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 UK
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 APAC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 AUSTRALIA & NEW ZEELAND
9.4.5 SOUTH KOREA
9.4.6 SINGAPORE
9.4.7 REST OF APAC
9.5 SOUTH AMERICA
9.5.1 BRAZIL
9.5.2 ARGENTINA
9.5.3 REST OF SOUTH AMERICA
9.6 MEA
9.6.1 SOUTH AFRICA
9.6.2 SAUDI ARABIA
9.6.3 UAE
9.6.4 REST OF MEA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET RANKING OF KEY PLAYERS, 2016
10.3 COMPETITIVE SCENARIO
10.4 NEW PRODUCT DEVELOPMENTS
10.5 EXPANSIONS
10.6 ACQUISITIONS
10.7 AGREEMENTS & PARTNERSHIPS
11 COMPANY PROFILES
(Business overview, Products offered, Recent developments, SWOT analysis & MnM View)*
11.1 ROYAL DSM N.V.
11.2 MEDTRONIC PLC
11.3 INTEGRA LIFESCIENCES CORPORATION
11.4 JOHNSON & JOHNSON
11.5 SMITH & NEPHEW PLC
11.6 MEDLINE INDUSTRIES, INC.
11.7 B. BRAUN MELSUNGEN AG
11.8 CARDINAL HEALTH, INC.
11.9 PAUL HARTMANN AG
11.10 BSN MEDICAL (A PART OF SVENSKA CELLULOSA AKTIEBOLAGET SCA)
*Details on Business overview, Products offered, Recent developments, SWOT analysis & MnM View might not be captured in case of unlisted companies.
11.11 OTHER COMPANIES
11.11.1 ATEX TECHNOLOGIES
11.11.2 ELKEM SILICONES
11.11.3 BALLY RIBBON MILLS
11.11.4 US BIODESIGN
11.11.5 NITTO DENKO CORPORATION
11.11.6 KIMBERLY-CLARK CORPORATION
11.11.7 M?LNLYCKE HEALTH CARE
11.11.8 3M COMPANY
11.11.9 AHLSTROM-MUNKSJ?
11.11.10 FREUDENBERG & CO. KOMMANDITGESELLSCHAFT
11.11.11 SECANT GROUP, LLC
11.11.12 MEISTER & CIE AG
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.2 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 SIGNIFICANT OPPORTUNITIES IN THE BIOMEDICAL TEXTILES MARKET
4.2 BIOMEDICAL TEXTILES MARKET, BY APPLICATION
4.3 BIOMEDICAL TEXTILES MARKET, BY COUNTRY AND REGION
4.4 US BIOMEDICAL TEXTILES MARKET, BY APPLICATION
4.5 BIOMEDICAL TEXTILES MARKET ATTRACTIVENESS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising number of surgeries
5.2.1.2 Rapid growth in aging population
5.2.1.3 High quality of biomedical textiles
5.2.1.4 Growing need for advanced wound dressing material
5.2.2 RESTRAINTS
5.2.2.1 High R&D investments
5.2.3 OPPORTUNITIES
5.2.3.1 Development of smart biomedical textiles
5.2.3.2 Growing demand from emerging markets
5.2.4 CHALLENGES
5.2.4.1 Increasing pricing pressure on market players
5.2.4.2 Product marketing
5.3 PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 INDUSTRY OUTLOOK
5.4.1 CONTRIBUTION OF THE HEALTHCARE INDUSTRY TO GDP
6 BIOMEDICAL TEXTILES MARKET, BY FIBER TYPE
6.1 INTRODUCTION
6.2 NON-BIODEGRADABLE FIBER
6.2.1 POLYPROPYLENE AND POLYETHYLENE
6.2.2 COTTON
6.2.3 VISCOSE
6.2.4 POLYESTER
6.2.5 POLYAMIDE
6.2.6 OTHERS
6.2.6.1 Polyurethane
6.2.6.2 Polytetrafluoroethylene(PTFE)
6.3 BIODEGRADABLE FIBER
6.3.1 COLLAGEN
6.3.2 CHITIN
6.3.3 OTHERS
7 BIOMEDICAL TEXTILES MARKET, BY FABRIC TYPE
7.1 INTRODUCTION
7.2 NON-WOVEN FABRIC
7.3 WOVEN FABRIC
7.4 OTHERS
7.4.1 KNITTED & BRAIDED FABRICS
7.4.2 HOLLOW FABRIC
8 BIOMEDICAL TEXTILES MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 NON-IMPLANTable
8.2.1 BANDAGES
8.3 SURGICAL SUTURES
8.4 OTHERS
8.4.1 IMPLANTable
8.4.1.1 Soft tissue implants
8.4.1.2 Hard tissue implants
8.4.1.3 Dental prosthesis
8.4.1.4 Vascular devices
8.4.2 EXTRACORPOREAL DEVICES
9 BIOMEDICAL TEXTILES MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.2.3 MEXICO
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 UK
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 APAC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 AUSTRALIA & NEW ZEELAND
9.4.5 SOUTH KOREA
9.4.6 SINGAPORE
9.4.7 REST OF APAC
9.5 SOUTH AMERICA
9.5.1 BRAZIL
9.5.2 ARGENTINA
9.5.3 REST OF SOUTH AMERICA
9.6 MEA
9.6.1 SOUTH AFRICA
9.6.2 SAUDI ARABIA
9.6.3 UAE
9.6.4 REST OF MEA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET RANKING OF KEY PLAYERS, 2016
10.3 COMPETITIVE SCENARIO
10.4 NEW PRODUCT DEVELOPMENTS
10.5 EXPANSIONS
10.6 ACQUISITIONS
10.7 AGREEMENTS & PARTNERSHIPS
11 COMPANY PROFILES
(Business overview, Products offered, Recent developments, SWOT analysis & MnM View)*
11.1 ROYAL DSM N.V.
11.2 MEDTRONIC PLC
11.3 INTEGRA LIFESCIENCES CORPORATION
11.4 JOHNSON & JOHNSON
11.5 SMITH & NEPHEW PLC
11.6 MEDLINE INDUSTRIES, INC.
11.7 B. BRAUN MELSUNGEN AG
11.8 CARDINAL HEALTH, INC.
11.9 PAUL HARTMANN AG
11.10 BSN MEDICAL (A PART OF SVENSKA CELLULOSA AKTIEBOLAGET SCA)
*Details on Business overview, Products offered, Recent developments, SWOT analysis & MnM View might not be captured in case of unlisted companies.
11.11 OTHER COMPANIES
11.11.1 ATEX TECHNOLOGIES
11.11.2 ELKEM SILICONES
11.11.3 BALLY RIBBON MILLS
11.11.4 US BIODESIGN
11.11.5 NITTO DENKO CORPORATION
11.11.6 KIMBERLY-CLARK CORPORATION
11.11.7 M?LNLYCKE HEALTH CARE
11.11.8 3M COMPANY
11.11.9 AHLSTROM-MUNKSJ?
11.11.10 FREUDENBERG & CO. KOMMANDITGESELLSCHAFT
11.11.11 SECANT GROUP, LLC
11.11.12 MEISTER & CIE AG
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 HEALTHCARE EXPENDITURE OF COUNTRIES IN APAC
Table 2 HEALTHCARE EXPENDITURE OF COUNTRIES IN NORTH AMERICA
Table 3 HEALTHCARE EXPENDITURE OF COUNTRIES IN EUROPE
Table 4 HEALTHCARE EXPENDITURE OF COUNTRIES IN SOUTH AMERICA
Table 5 HEALTHCARE EXPENDITURE OF COUNTRIES IN MEA
Table 6 BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE, 2015–2022 (USD MILLION)
Table 7 NON-BIODEGRADABLE FIBER MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 8 BIODEGRADABLE FIBER MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 9 BIOMEDICAL TEXTILES MARKET SIZE, BY FABRIC TYPE, 2015–2022 (USD MILLION)
Table 10 NON-WOVEN FABRIC MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 11 WOVEN FABRIC MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 12 OTHER FABRICS MARKET SIZE , BY REGION, 2015–2022 (USD MILLION)
Table 13 BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 14 BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTable APPLICATION, BY REGION, 2015–2022 (USD MILLION)
Table 15 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTable APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 16 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTable APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 17 APAC: BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTable APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 18 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTable APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 19 MEA: BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTable APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 20 BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION, BY REGION, 2015–2022 (USD MILLION)
Table 21 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 22 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 23 APAC: BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 24 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 25 MEA: BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 26 BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
Table 27 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 28 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 29 APAC: BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 30 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 31 MEA: BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 32 BIOMEDICAL TEXTILES MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 33 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE, 2015–2022 (USD MILLION)
Table 34 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 35 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 36 US: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 37 CANADA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 38 MEXICO: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 39 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE, 2015–2022 (USD MILLION)
Table 40 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 41 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 42 GERMANY: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 43 FRANCE: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 44 UK: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 45 ITALY: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 46 SPAIN: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 47 APAC: BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE, 2015–2022 (USD MILLION)
Table 48 APAC: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 49 APAC: BIOMEDICAL TEXTILES MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 50 CHINA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 51 JAPAN: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 52 INDIA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 53 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE, 2015—2022 (USD MILLION)
Table 54 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015—2022 (USD MILLION)
Table 55 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY COUNTRY, 2015—2022 (USD MILLION)
Table 56 MEA: BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE, 2015—2022 (USD MILLION)
Table 57 MEA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015—2022 (USD MILLION)
Table 58 MEA: BIOMEDICAL TEXTILES MARKET SIZE, BY COUNTRY, 2015—2022 (USD MILLION)
Table 59 NEW PRODUCT DEVELOPMENTS, 2016–2018
Table 60 EXPANSIONS, 2016-2018
Table 61 ACQUISITIONS, 2016-2018
Table 62 AGREEMENTS & PARTNERSHIPS, 2016-2018
Table 1 HEALTHCARE EXPENDITURE OF COUNTRIES IN APAC
Table 2 HEALTHCARE EXPENDITURE OF COUNTRIES IN NORTH AMERICA
Table 3 HEALTHCARE EXPENDITURE OF COUNTRIES IN EUROPE
Table 4 HEALTHCARE EXPENDITURE OF COUNTRIES IN SOUTH AMERICA
Table 5 HEALTHCARE EXPENDITURE OF COUNTRIES IN MEA
Table 6 BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE, 2015–2022 (USD MILLION)
Table 7 NON-BIODEGRADABLE FIBER MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 8 BIODEGRADABLE FIBER MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 9 BIOMEDICAL TEXTILES MARKET SIZE, BY FABRIC TYPE, 2015–2022 (USD MILLION)
Table 10 NON-WOVEN FABRIC MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 11 WOVEN FABRIC MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 12 OTHER FABRICS MARKET SIZE , BY REGION, 2015–2022 (USD MILLION)
Table 13 BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 14 BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTable APPLICATION, BY REGION, 2015–2022 (USD MILLION)
Table 15 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTable APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 16 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTable APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 17 APAC: BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTable APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 18 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTable APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 19 MEA: BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTable APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 20 BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION, BY REGION, 2015–2022 (USD MILLION)
Table 21 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 22 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 23 APAC: BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 24 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 25 MEA: BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 26 BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
Table 27 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 28 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 29 APAC: BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 30 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION)
Table 31 MEA: BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 32 BIOMEDICAL TEXTILES MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 33 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE, 2015–2022 (USD MILLION)
Table 34 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 35 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 36 US: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 37 CANADA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 38 MEXICO: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 39 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE, 2015–2022 (USD MILLION)
Table 40 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 41 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 42 GERMANY: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 43 FRANCE: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 44 UK: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 45 ITALY: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 46 SPAIN: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 47 APAC: BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE, 2015–2022 (USD MILLION)
Table 48 APAC: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 49 APAC: BIOMEDICAL TEXTILES MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 50 CHINA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 51 JAPAN: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 52 INDIA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 53 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE, 2015—2022 (USD MILLION)
Table 54 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015—2022 (USD MILLION)
Table 55 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY COUNTRY, 2015—2022 (USD MILLION)
Table 56 MEA: BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE, 2015—2022 (USD MILLION)
Table 57 MEA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION, 2015—2022 (USD MILLION)
Table 58 MEA: BIOMEDICAL TEXTILES MARKET SIZE, BY COUNTRY, 2015—2022 (USD MILLION)
Table 59 NEW PRODUCT DEVELOPMENTS, 2016–2018
Table 60 EXPANSIONS, 2016-2018
Table 61 ACQUISITIONS, 2016-2018
Table 62 AGREEMENTS & PARTNERSHIPS, 2016-2018
LIST OF FIGURES
Figure 1 BIOMEDICAL TEXTILES MARKET SEGMENTATION
Figure 2 BIOMEDICAL TEXTILES MARKET: RESEARCH DESIGN
Figure 3 BIOMEDICAL TEXTILES MARKET: DATA TRIANGULATION
Figure 4 NON-WOVEN FABRIC TO LEAD THE BIOMEDICAL TEXTILES MARKET BETWEEN 2017 AND 2022
Figure 5 NON-IMPLANTable TO BE THE FASTEST-GROWING APPLICATION OF BIOMEDICAL TEXTILES BETWEEN 2017 AND 2022
Figure 6 NON-BIODEGRADABLE FIBER TO LEAD THE BIOMEDICAL TEXTILES MARKET DURING THE FORECAST PERIOD
Figure 7 CHINA TO REGISTER THE HIGHEST CAGR IN THE BIOMEDICAL TEXTILES MARKET DURING THE FORECAST PERIOD
Figure 8 APAC TO BE THE FASTEST-GROWING BIOMEDICAL TEXTILES MARKET DURING THE FORECAST PERIOD
Figure 9 THE BIOMEDICAL TEXTILES MARKET TO REGISTER SIGNIFICANT CAGR BETWEEN 2017 AND 2022
Figure 10 NON-IMPLANTable TO BE THE LARGEST APPLICATION OF BIOMEDICAL TEXTILES DURING THE FORECAST PERIOD
Figure 11 US ACCOUNTED FOR THE LARGEST BIOMEDICAL TEXTILES MARKET SHARE IN 2016
Figure 12 NON-IMPLANTable APPLICATION TO ACCOUNT FOR THE LARGEST SHARE BETWEEN 2017 AND 2022
Figure 13 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 14 OVERVIEW OF FACTORS GOVERNING THE BIOMEDICAL TEXTILES MARKET
Figure 15 PORTER’S FIVE FORCES ANALYSIS
Figure 16 NON-BIODEGRADABLE FIBER TO DOMINATE THE BIOMEDICAL TEXTILES MARKET BETWEEN 2017 AND 2022
Figure 17 NORTH AMERICA TO BE THE LARGEST MARKET FOR NON-BIODEGRADABLE FIBER BETWEEN 2017 AND 2022
Figure 18 NON-WOVEN FABRIC TO DOMINATE THE BIOMEDICAL TEXTILES MARKET BETWEEN 2017 AND 2022
Figure 19 APAC TO BE THE FASTEST-GROWING NON-WOVEN FABRIC MARKET BETWEEN 2017 AND 2022
Figure 20 NORTH AMERICA TO BE THE LARGEST MARKET FOR OTHER FABRICS BETWEEN 2017 AND 2022
Figure 21 NON-IMPLANTable TO BE THE LARGEST APPLICATION OF BIOMEDICAL TEXTILES BETWEEN 2017 AND 2022
Figure 22 APAC TO BE THE LARGEST BIOMEDICAL TEXTILES MARKET IN SURGICAL SUTURES APPLICATION BETWEEN 2017 AND 2022
Figure 23 NORTH AMERICA TO BE THE LARGEST BIOMEDICAL TEXTILES MARKET IN OTHER APPLICATIONS BETWEEN 2017 AND 2022
Figure 24 US LEADS THE BIOMEDICAL TEXTILES MARKET
Figure 25 GERMANY TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 26 CHINA DOMINATES THE BIOMEDICAL TEXTILES MARKET
Figure 27 COMPANIES ADOPTED NEW PRODUCT DEVELOPMENTS AS THE KEY GROWTH STRATEGY BETWEEN 2016 AND 2018
Figure 28 ROYAL DSM N.V.: COMPANY SNAPSHOT
Figure 29 MEDTRONIC PLC: COMPANY SNAPSHOT
Figure 30 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
Figure 31 JOHNSON & JOHNSON: COMPANY SNAPSHOT
Figure 32 SMITH & NEPHEW PLC: COMPANY SNAPSHOT
Figure 33 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2016)
Figure 34 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
Figure 35 PAUL HARTMANN AG: COMPANY SNAPSHOT
Figure 1 BIOMEDICAL TEXTILES MARKET SEGMENTATION
Figure 2 BIOMEDICAL TEXTILES MARKET: RESEARCH DESIGN
Figure 3 BIOMEDICAL TEXTILES MARKET: DATA TRIANGULATION
Figure 4 NON-WOVEN FABRIC TO LEAD THE BIOMEDICAL TEXTILES MARKET BETWEEN 2017 AND 2022
Figure 5 NON-IMPLANTable TO BE THE FASTEST-GROWING APPLICATION OF BIOMEDICAL TEXTILES BETWEEN 2017 AND 2022
Figure 6 NON-BIODEGRADABLE FIBER TO LEAD THE BIOMEDICAL TEXTILES MARKET DURING THE FORECAST PERIOD
Figure 7 CHINA TO REGISTER THE HIGHEST CAGR IN THE BIOMEDICAL TEXTILES MARKET DURING THE FORECAST PERIOD
Figure 8 APAC TO BE THE FASTEST-GROWING BIOMEDICAL TEXTILES MARKET DURING THE FORECAST PERIOD
Figure 9 THE BIOMEDICAL TEXTILES MARKET TO REGISTER SIGNIFICANT CAGR BETWEEN 2017 AND 2022
Figure 10 NON-IMPLANTable TO BE THE LARGEST APPLICATION OF BIOMEDICAL TEXTILES DURING THE FORECAST PERIOD
Figure 11 US ACCOUNTED FOR THE LARGEST BIOMEDICAL TEXTILES MARKET SHARE IN 2016
Figure 12 NON-IMPLANTable APPLICATION TO ACCOUNT FOR THE LARGEST SHARE BETWEEN 2017 AND 2022
Figure 13 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 14 OVERVIEW OF FACTORS GOVERNING THE BIOMEDICAL TEXTILES MARKET
Figure 15 PORTER’S FIVE FORCES ANALYSIS
Figure 16 NON-BIODEGRADABLE FIBER TO DOMINATE THE BIOMEDICAL TEXTILES MARKET BETWEEN 2017 AND 2022
Figure 17 NORTH AMERICA TO BE THE LARGEST MARKET FOR NON-BIODEGRADABLE FIBER BETWEEN 2017 AND 2022
Figure 18 NON-WOVEN FABRIC TO DOMINATE THE BIOMEDICAL TEXTILES MARKET BETWEEN 2017 AND 2022
Figure 19 APAC TO BE THE FASTEST-GROWING NON-WOVEN FABRIC MARKET BETWEEN 2017 AND 2022
Figure 20 NORTH AMERICA TO BE THE LARGEST MARKET FOR OTHER FABRICS BETWEEN 2017 AND 2022
Figure 21 NON-IMPLANTable TO BE THE LARGEST APPLICATION OF BIOMEDICAL TEXTILES BETWEEN 2017 AND 2022
Figure 22 APAC TO BE THE LARGEST BIOMEDICAL TEXTILES MARKET IN SURGICAL SUTURES APPLICATION BETWEEN 2017 AND 2022
Figure 23 NORTH AMERICA TO BE THE LARGEST BIOMEDICAL TEXTILES MARKET IN OTHER APPLICATIONS BETWEEN 2017 AND 2022
Figure 24 US LEADS THE BIOMEDICAL TEXTILES MARKET
Figure 25 GERMANY TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 26 CHINA DOMINATES THE BIOMEDICAL TEXTILES MARKET
Figure 27 COMPANIES ADOPTED NEW PRODUCT DEVELOPMENTS AS THE KEY GROWTH STRATEGY BETWEEN 2016 AND 2018
Figure 28 ROYAL DSM N.V.: COMPANY SNAPSHOT
Figure 29 MEDTRONIC PLC: COMPANY SNAPSHOT
Figure 30 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
Figure 31 JOHNSON & JOHNSON: COMPANY SNAPSHOT
Figure 32 SMITH & NEPHEW PLC: COMPANY SNAPSHOT
Figure 33 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2016)
Figure 34 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
Figure 35 PAUL HARTMANN AG: COMPANY SNAPSHOT
